Developing methods | CHDR Annual Report

CHDR Annual Report 2023

Developing methods

Developing precise, data-rich methods for early clinical drug research is one of the unique aspects of CHDR’s work. 2023 saw new developments in methods for neurology, immunology, oncology, and more.

What can oncology research teach us about drug development in psychiatry?

Extracting valuable extra information from the EEG

New study design with well-known drug for CHDR’s first integrative oncology study

Deep phenotyping patients to improve drug development

New tests to measure drug effects on psychological functioning

CNS Profiler will facilitate NeuroCart studies at other sites

Excitability in pain research

RNA sequencing bridges preclinical models and clinical applications

In-depth profiling of mild psoriasis patients paves the way for future trials

Dopamine, novelty and motivation: an academic collaboration

Deep phenotyping is core aim of national immunodermatology consortium

Back to homepage